News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Thor Halfdanarson: Is it Effective and Safe to Use Lu-177 DOTATATE PRRT in Patients With NETs and Extensive Bone Metastases?
Thor Halfdanarson/mayoclinic.org
May 25, 2025, 05:33

Thor Halfdanarson: Is it Effective and Safe to Use Lu-177 DOTATATE PRRT in Patients With NETs and Extensive Bone Metastases?

Thor Halfdanarson, Medical Oncologist at the Mayo Clinic, shared a post on X:

“Lu-177 DOTATATE PRRT in patients with NETs and extensive bone metastases. Is it effective and is it safe?
It looks like the answer is yes to both and indeed, we use it frequently under such circumstances. Skeletal related events were 20%…”

Title: Clinical Outcomes of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Skeletal Metastases from Neuroendocrine Tumors: Insights from Real-World Experience

Authors: Kunal Ramesh Chandekar, Swayamjeet Satapathy, Sanjana Ballal, Madhav Prasad Yadav, Shubha Gadde Ravindra, Sameer Rastogi, Ranjit Kumar Sahoo, Chandrasekhar Bal

You can read the Full Article on Journal of Nuclear Medicine.

Thor Halfdanarson: Is it Effective and Safe to Use Lu-177 DOTATATE PRRT in Patients With NETs and Extensive Bone Metastases?

More posts featuring Thor Halfdanarson.

cancer Chandrasekhar Bal Kunal Ramesh Chandekar Madhav Prasad Yadav NETs OncoDaily Oncology Ranjit Kumar Sahoo Sameer Rastogi Sanjana Ballal Shubha Gadde Ravindra Swayamjeet Satapathy Thor Halfdanarson
Special Coverage
Blog
May 25, 2025, 05:33
Thor Halfdanarson: Is it Effective and Safe to Use Lu-177 DOTATATE PRRT in Patients With NETs and Extensive Bone Metastases?
Blog
May 25, 2025, 05:14
Bernard Fox: 47 hours of Great Science and Best Discussion at TIMO 2025
Blog
May 25, 2025, 05:02
Olubukola Ayodele: Cancer Isn’t Just a Diagnosis - It’s a Part of Life We All Need to Understand
Career
May 25, 2025, 04:48
Supriya Peshin Started a New Position as a Visiting Resident in Hematology and Oncology at MD Anderson Cancer Center
Blog
May 25, 2025, 02:33
United by Unique: Reflections on the World Cancer Day 2025 Impact Report
Insight
May 24, 2025, 20:22
ESMO-Magnitude of Clinical Benefit Scale version 2.0
Blog
May 24, 2025, 20:10
Miriam Mutebi: Join AORTIC Networking Reception at ASCO 2025 in Chicago
Career
May 24, 2025, 20:00
Ashok Sebastian Komaranchath Has Been Appointed as Consultant and Clinical Lead at Burjeel Cancer Institute, Oman
Insight
May 24, 2025, 19:52
Yan Leyfman: GLP-1 Receptor Agonists may Modestly Reduce the Risk of Developing Certain Cancers
Positive
May 24, 2025, 19:45
Susanna Fletcher Greer: Celebrating Personal Milestones While Advancing Cancer Research
Positive
May 24, 2025, 19:31
Ashok Sebastian Komaranchath: Burjeel Cancer Institute has Opened its 9th Branch at Muscat, Oman
Societies
May 24, 2025, 19:27
Azin Alizadehasl and IC-OS Iran Chapter members co-edited new book on Cardiovascular Considerations in Stem Cell Transplantation